| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/19/2009 | US20090076028 Deuterium-enriched itraconazole |
| 03/19/2009 | US20090076026 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects of dry-mouth and constipation; biphenyl carbamate derivatives; biphenyl-2-ylcarbamic acid 1-(3-(3-[3-(4-hydroxybenzylamino)propyl]-2-oxoimidazolidin-1-yl)propyl)piperidin-4-yl ester |
| 03/19/2009 | US20090075981 INHIBITORS OF p38 |
| 03/19/2009 | US20090075978 Substituted propiolic acid amides and their use for producing drugs |
| 03/19/2009 | US20090075959 Deuterium-enriched ciclesonide |
| 03/19/2009 | US20090075892 Synthetic pulmonary surfactant peptides |
| 03/19/2009 | US20090074873 Nanoparticulate beclomethasone dipropionate compositions |
| 03/19/2009 | US20090074830 Anti-angiogenic compositions and methods of use |
| 03/19/2009 | US20090074807 Moraxella (branhamella) catarrhalis antigens |
| 03/19/2009 | US20090074788 Antibody Against Periostin, and a Pharmaceutical Composition comprising it for Preventing or Treating a Disease in which Periostin is Involved |
| 03/19/2009 | CA2731204A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2704726A1 Use of a defensin peptide as a therapeutic agent |
| 03/19/2009 | CA2699222A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2699215A1 (d-leu7 ) -histrelin as a therapeutic agent |
| 03/19/2009 | CA2699167A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2699026A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2699020A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2699012A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2699010A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2699008A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2699006A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698992A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698985A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698984A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698981A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698980A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698978A1 Use of human neuropeptide af as a therapeutic agent |
| 03/19/2009 | CA2698977A1 Use of c-type natriuretic peptide, alone or incombination with neuropeptide af, as a therapeutic agent |
| 03/19/2009 | CA2698976A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698974A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698971A1 Use of urodilatin as a therapeutic agent |
| 03/19/2009 | CA2698966A1 Use of fertirelin and delta-endorphin as therapeutic agents |
| 03/19/2009 | CA2698963A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698912A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698855A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698852A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698833A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698828A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698824A1 Use of peptide yy, alone or in combination with glucagon-like peptide, for use in medicine |
| 03/19/2009 | CA2698822A1 Minigastrin as a therapeutic agent |
| 03/19/2009 | CA2698821A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698786A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698783A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698778A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698770A1 Use of secretin and optionally urodilatin as a therapeutic agents |
| 03/19/2009 | CA2698759A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698754A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698748A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698745A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698693A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698691A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698682A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698666A1 Use of a peptide as a therapeutic agent |
| 03/18/2009 | EP2036905A1 Pyridylisoxazole derivative |
| 03/18/2009 | EP2036898A2 Method for manufacturing 1.3 dioxolane 2ones and carboxylic acid esters by transacylation under alkaline reaction conditions |
| 03/18/2009 | EP2036895A1 Hsp90 inhibitor |
| 03/18/2009 | EP2036891A2 Isoquinoline inhibitors of P38 |
| 03/18/2009 | EP2036560A1 (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione for the treatment of benign prostatic hypertrophy |
| 03/18/2009 | EP2036549A1 Novel Composition |
| 03/18/2009 | EP2035573A1 Methods for identifying modulators of eoxin formation |
| 03/18/2009 | EP2035386A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 03/18/2009 | EP2035369A1 Therapeutic compounds |
| 03/18/2009 | EP2035025A1 Use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition and method for producing the same |
| 03/18/2009 | EP2035010A1 Modulation of the immune system by inositol phospholipids |
| 03/18/2009 | EP2035004A1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 03/18/2009 | EP2034832A2 Il-8 receptor antagonist |
| 03/18/2009 | EP1656346B1 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases |
| 03/18/2009 | EP1515745B1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 03/18/2009 | EP1513806B1 Sulphonic acid salts of mandelic acid derivatives |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | EP1283887B1 Chimeric arterivirus-like particles |
| 03/18/2009 | CN101389656A Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same |
| 03/18/2009 | CN101389611A Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 03/18/2009 | CN101389610A Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 03/18/2009 | CN101389340A Combinations of steroids and methylxanthine compounds |
| 03/18/2009 | CN101386848A MiRNA with cell corpuscule as vector and preparation research approach thereof and application |
| 03/18/2009 | CN101385848A Medicine for treating bronchitis |
| 03/18/2009 | CN101385847A Preparation method of minor decoction of green dragon |
| 03/18/2009 | CN101385833A Eucalyptus leaf cough syrup and preparation method thereof |
| 03/18/2009 | CN101385828A Traditional Chinese medicine for treating urgent and chronic inflammation of upper respiratory tract |
| 03/18/2009 | CN101385825A Traditional Chinese medicine preparation for preventing and treating cold |
| 03/18/2009 | CN101385821A Asthma control coating agent and preparation technique thereof |
| 03/18/2009 | CN101385817A Medicine for external application for curing rhinitis and its preparation method |
| 03/18/2009 | CN101385802A Traditional Chinese medicine for treating tummy, duodenal ulcer and bronchitis |
| 03/18/2009 | CN101385772A Effervescence tablets for increasing natural immunity |
| 03/18/2009 | CN101385740A Use of polysaccharide sulfate as anti influenza virus medicine |
| 03/18/2009 | CN101385539A Wean diet therapy method for eliminating the phlegm, cleaning the heat and nourishing the liver |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/18/2009 | CN100469378C Pharmaceutical composition for treating pharyngitis |
| 03/18/2009 | CN100469374C Method for preparing cough-relieving apophlegmatic Mogolian medicine |
| 03/18/2009 | CN100469371C Manufacturing technique for gingko leaf extracts |
| 03/18/2009 | CN100469363C Therapeutic combinations of fatty acids |
| 03/18/2009 | CN100469361C Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/17/2009 | US7504432 Quaternary salt of (3-((2-(3,3-difluorocyclopentyl)-2-hydroxy-2-(4-methylphenyl)ethanoyl)oxy)-1,1-dimethylpyrrolidinium bromide; respiratory system disorders; chronic obstructive pulmonary diseases, bronchitis, asthma, emphysema, rhinitis; side effect reduction; inhalants; muscarinic receptor antagonists |
| 03/17/2009 | US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/17/2009 | US7504409 Chronic obstructive pulmonary disease; asthma; respiratory system disorders; administering 2-aminonicotinic acid, anthranilic acid, bendroflumethiazide |
| 03/17/2009 | US7504407 2-substituted-4-(imidazolyl or pyrazolyl alkyl)amino-6-phenyl-pyrrolo[2,3-D]pyrimidines; Adenosine receptor inhibitors; asthma, bronchodilators, vision defects, antiischemic and antiinflammatory agents |
| 03/17/2009 | US7504398 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation |